Using Novel Immune Modulatory Treatment Options in Head and Neck Cancer: On-Demand Simulcast
Source: Overcoming Medical Challenges in Head and Neck Cancer Using Novel Immune Modulatory Treatment Options: An Evening With the Experts

Video Module

Did you miss the symposium in Scottsdale? Review this on-demand simulcast of the live event as our distinguished faculty, Maura L. Gillison, MD, PhD; Barbara Ann Burtness, MD; and Everett Vokes, MD review practical guidance in integrating immunotherapy agents into therapeutic strategies to improve outcomes for patients with HNSCC.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Explain the role of the immune system and immune escape in HNSCC, along with the mechanisms of action of different immune modulatory agents
  • Plan therapeutic strategies for patients with recurrent metastatic HNSCC that has progressed on or after platinum-containing chemotherapy
  • Discuss the latest science and clinical trial results of immunotherapy agents or combinations being investigated as first-line treatment of locoregionally advanced or metastatic HNSCC
  • Identify appropriate candidates for clinical trials of IDO inhibitors and other emerging immune modulatory agents alone or in combination for HNSCC
  • Identify and manage immune-related toxicities associated with immune checkpoint inhibitors in patients with HNSCC
CCO Video Modules contain video commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.


  • Maura L. Gillison
    MD, PhD
    Barbara Ann Burtness
    Everett Vokes

Credit Information

  • Release Date:
    March 09, 2018
  • Expiration Date:
    March 08, 2019